Nancy Levy Email & Phone Number

Cambridge, Massachusetts

Boston Landing was created to give international companies support in US business practices and US market entry strategies and the opportunity to experience these in the US, offering many different services and programs to meet the needs and budgets of their clients. Our team works to define a program to meet the client’s needs for growth and development taking advantage of what the US has to offer. Our goal is to help the client achieve success based on their time frame and their needs. Our programs include the Entrepreneur's Academy and the Boston Landing Accelerator, boot-camps, workshops and one-on-one mentoring for entrepreneurs and academic entrepreneurs. This includes strategy review to evaluate their business and positioning, pitch and brand coaching to communicate their message. Included are training on advanced entrepreneurial skills and executive preparation for financing and partnering including US business practices and the development of market appropriate documents. The program combines office space at the Cambridge Innovation Center (CIC), an entrepreneurial community in the heart of the Cambridge, Massachusetts innovation cluster, with the coaching, mentoring, and consulting expertise of the Boston Landing team. Boston innovation ecosystem includes life sciences, high tech, clean energy, maritime and aerospace. Boston Landing allows companies to become part of the Boston community at their own pace and level, with little risk, gaining the knowledge, capabilities and relationships for success in the US.

Boston, Massachusetts

Nancy Levy is the Managing Partner and founder of BioHealth Management LLC, a biomedical commercial strategy and business development consulting firm focused on US business practices and US market entry strategies. Founded in 1994, BioHealth Management comprises senior experts specializing in growth strategies based on market, business, and financial development. Hired on a project-by-project basis, BioHealth has a hands-on style and high level of involvement in designing and implementing business strategies to ensure success. The organization works closely with clients to understand their technologies and develop clear and achievable strategies and goals. BioHealth has built its reputation on strong analytical capabilities and deep industry knowledge, reinforced by an extended network of renowned opinion leaders.Biohealth has been involved in partnering over 40 drugs and devices, and in investor meetings for over 50 companies. They have managed 15 international events for multiple countries and have managed 6 successful Orphan Drug applications with FDA and EMEA.

Managed successful Phase II trial. Established a collaboration with alliance partner, Genentech. Managed process for development of Phase II product with potential first drug in indication.• Championed Genentech alliance for product with royalty stream worth over $500 M. • Identified licensing opportunity for autoimmune compounds including NPV and financial analysis.• Accelerated positive end-point for Phase II trial for first marketable drug for indication.

Served for four years as President and CEO of Immunetics, a medical devices company located in Cambridge, MA where she raised three rounds of financing, wrote multiple grants and managed the processes for the first FDA products.Hired to plan and execute strategic business plan and capitalization strategy• Due-diligence and alliance management with large multi-national bio-instruments company • Built GMP capabilities and achieved first FDA approved products. Executive Vice President Business Development • Implemented financial analysis and portfolio planning into operating business.• Built global sales, doubling revenue, through licensing deals and joint ventures.

Senior Product Manager, Virotech GmbH • Due-diligence and alliance management of Virotech, Russelsheim, Germany, a $10 million infectious disease company, acquired by the Diagnostics’ Division.• Managed regulatory and commercial introduction into the USA.Marketing Manager, Clinical Program Manager, Immunobiologicals, • Built clinical and GMP capabilities and first FDA approved products from business unit.• Developed and championed new product line with initial sales of $4 million in Europe through direct sales and licensing.

Cambridge, Ma

Developed and taught a full year course on Microbiology and infectious diseases. Focus of course was how micro-organisms grow and develop and how they cause diseases. Discussion of prevention, therapeutics, diagnostics and vaccines included.